Outpatient Parenteral Antibiotic Therapy (OPAT) Conference & Workshops

Part of the BSAC OPAT Initiative

2016 Conference

How can OPAT help deliver the NHS Five Year Forward View?

Philip Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals NHS Trust, Leeds

Download Slides

Endocarditis

Jonathan Sandoe, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds

Download Slides

Spinal Infections

Neil Ritchie, Clinical Lecturer in Infectious Diseases, Queen Elizabeth University Hospital, Glasgow

Download Slides

Paediatrics – a special population?

Sanjay Patel, Consultant Paediatrician, Southampton Children’s Hospital, Southampton

Download Slides

Clinical efficacy, cost-analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield OPAT service

Chris Durojaiye, Locum Consultant Physician, Royal Hallamshire Hospital, Sheffield

Download Slides

A re-audit evaluating the management of OPAT bronchiectasis patients against current BTS guidelines

Heather Boniface, F2-Paediatrics, Princess Royal Hospital, Telford

Download Slides

Success of an outpatient parenteral antimicrobial therapy (OPAT) programme in a large UK paediatric hospital

David Porter, Consultant in Paediatric Infectious Diseases, Alder Hey Hospital, Liverpool

Download Slides

Self-administration of intravenous antibiotics for OPAT

Emma Nickerson, Associate Specialist in Infectious Disease, Addenbrookes, Cambridge<

Download Slides

Learning outcome: Examining how to choose the right agent in the ambulatory care setting, including a review of licensed agents and drivers for prescribing – cost versus convenience versus stewardship versus stability

Susan Snape, Consultant Microbiologist, Nottingham University Hospitals, Nottingham
Sarah Williams, Deputy Lead Specialist Nurse, Nottingham University Hospitals, Nottingham
Tim Hills, OPAT Pharmacist, Nottingham University Hospitals, Nottingham
Elizabeth Hart, Infectious Disease and Acute Medicine Physician, Nottingham University Hospitals, Nottingham

Download Slides

Learning outcomes: Examining key factors in establishing admission avoidance services through safe, competency led services and appropriate patient selection

Sharon Bamber, OPAT Service Lead, Wirral University Teaching Hospital NHS, Merseyside
John Cunniffe, Consultant Microbiologist, Wirral University Teaching Hospital NHS, Merseyside

Download Slides

IVOST: principles and practice in OPAT

Andrew Seaton, Consultant Physician, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde

Download Slides

Oral Versus Intra-venous Antibiotic Treatment for Bone and Joint Infections

Matthew Scarborough, Infectious Diseases Consultant, Oxford University Hospitals NHS Trust, Oxford

Download Slides

Resurgence of older oral therapies in OPAT

Carolyn Hemsley, Consultant ID and Microbiology, Guys and St Thomas’s Hospital, London

Download Slides

Introduction: Tip location, CLABSI, Midlines and Passports

Andrew Jackson, IV Nurse Consultant, The Rotherham NHS Foundation Trust, Rotherham

Download Slides

Infection Prevention and Vascular Access

Martin Kiernan, Visiting Clinical Fellow, University of West London – GAMA Healthcare, London

Download Slides

Vessel Health and Preservation Framework

Tim Jackson, Consultant Anaesthetist & Intensivist at Calderdale & Huddersfield NHS Foundation Trust, Huddersfield

Download Slides

ECG PICC Tip Location

Gemma Oliver, Nurse Consultant Integrated IV Care at East Kent Hospitals University NHS Foundation Trust, Kent

Download Slides

Clinical efficacy of daily parenteral infusions of meropenem and ampicillin in the OPAT setting

James Pollard, Clinical Director, Hospital in the Home, Victoria, Australia

Download Slides

Instructive Endocarditis Case

Jonathan Sandoe, Associate Clinical Professor/Honorary Consultant Microbiologist, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds

Download Slides

A Case of Unintended Consequences – lessons to be learned

Beth White, Queen Elizabeth University Hospital, Glasgow

Download Slides

Staphylococcus aureus Bacteraemia & optimal OPAT management – doing the right thing isn’t always easy!

Eoghan de Barra, Consultant Infectious Diseases, Imperial College Healthcare Trust, London

Download Slides

Treating MDR Negatives in OPAT

Fiona Robb, Antimicrobial Pharmacist, NHS Greater Glasgow and Clyde, Glasgow

Download Slides

Paediatric OPAT: an Australasian approach

Penelope Bryant, Australasian Paediatric Antimicrobial Stewardship Group, Australia

Download Slides

Proving cost effectiveness in OPAT – what a commissioner needs to know

Sue Snape, Consultant Microbiologist, Nottingham University Hospitals, Nottingham

Download Slides

Community practice

Kate Owen, District Nurse Community IV Team Leader, Dudley Group of Hospitals NHS Trust, West Midlands

Download Slides

Acute practice

Gemma Oliver, Nurse Consultant IV Care, East Kent Hospital University NHS Trust, Kent

Download Slides

Establishing a regional the West Midland IV Forum

Kate Owen, District Nurse Community IV Team Leader, Dudley Group of Hospitals NHS Trust, West Midlands

Download Slides

Next steps and close

Download Slides

NIHR Summary of OPAT work

Jane Minton, Consultant in Infectious Diseases, Leeds Teaching Hospitals, Leeds

Download Slides

Revised EPIC3 guidelines impact on OPAT

Kate Owen, District Nurse Community IV Team Leader, The Dudley Group NHS Foundation Trust, Dudley

Download Slides

Drug stability – why open access publication of stability data is essential

Mark Santillo, Regional Quality Assurance Officer, Torbay & South Devon NHS Foundation Trust, Torquay

Download Slides

CLOSING REMARKS – Where next for the OPAT in the UK?

Mark Gilchrist, Consultant Pharmacist in Infectious Diseases, Imperial College Healthcare NHS Trust, London

Download Slides

Top